Business Wire

Sintavia Chosen to Represent AM Supply Chain for Aerospace & Defense in Launch of Major White House Initiative

9.5.2022 16:00:00 EEST | Business Wire | Press release

Share

Sintavia, LLC, a designer and additive manufacturer of advanced propulsion and thermodynamic systems for the Aerospace, Defense, & Space industry, announced today that it had been chosen to represent the AM supply chain in the launch of a major White House initiative called “AM Forward”. This new initiative, unveiled on May 6th by President Biden in Cincinnati, is a voluntary compact between large, iconic manufacturers and their smaller U.S.-based suppliers. GE Aviation, Honeywell, Lockheed Martin, Raytheon, and Siemens Energy are the initial participants in AM Forward. Each of these aerospace OEMs had the opportunity to nominate an AM supplier to participate in the launch, and Sintavia was chosen by both Lockheed Martin and Honeywell Aerospace.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220508005087/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

President Biden inspects large, printed aerospace components and meets with senior leadership from Sintavia, Lockheed Martin, and Honeywell in Cincinnati on May 6, 2022 to launch the new White House “AM Forward” supply chain initiative (from left to right, Frank St. John, COO, Lockheed Martin; Mike Madsen, CEO, Honeywell Aerospace; Brian Neff, Founder & CEO, Sintavia). Photo Courtesy: AP/Andrew Harnik

The AM Forward compact will focus on (i) building a more resilient and innovative supply chain through investments in small and medium-sized companies that adopt new technologies such as AM, (ii) overcoming coordination challenges that limit the adoption of new manufacturing technologies such as AM, and (iii) developing regional AM ecosystems to fundamentally enhance domestic production of high-value industrial products.

“We were very honored to be chosen by both Lockheed Martin and Honeywell Aerospace to represent the AM supply chain in the launch of this exciting new initiative,” said Brian Neff, Sintavia’s Founder & CEO. “The products that we design and print already power and cool the flight and launch vehicles of tomorrow, but the use case potential is practically limitless and the transformation is just getting started. AM Forward is an initiative that is critical to the long-term viability of American manufacturing, and we similarly call on Congress to pass the Bipartisan Innovation Act to advance research and development into additive manufacturing and other transformational manufacturing technologies.”

The Bipartisan Innovation Act (BIA), which is currently in legislative conference, would further enhance the goals of AM Forward by establishing a Supply Chain Office at the Department of Commerce, supporting foundational technologies such as additive manufacturing, and investing in regional tech hubs. The BIA would also increase funding for Manufacturing USA Institutes and the Manufacturing Extension Partnership.

About Sintavia

Sintavia designs and 3D prints advanced propulsion and thermodynamic systems for customers in the Aerospace, Defense, & Space industry. A founding member of the Additive Manufacturer Green Trade Association, Sintavia is committed to the highest quality standards in the industry and holds multiple Nadcap and other aerospace accreditations. For more information visit http://www.sintavia.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Sintavia, LLC
Lindsay Lewis
+1 954.474.7800

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 12:18:00 EEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises22.5.2026 11:11:00 EEST | Press release

Global IT corporation FPT announced the launch of Flezi Foundry™ (FPT Digital Foundry™), an AI-augmented delivery platform for software development and IT operations. Built around a governed Service-as-a-Software model, the platform combines autonomous AI agents, human expert oversight, secure infrastructure, and outcome-based delivery mechanisms to help enterprises modernize technology delivery as AI agents become part of software engineering and IT operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521235556/en/ Flezi Foundry applies Agentic Engineering, a structured delivery approach for software development and IT operations. The model brings AI agents into delivery workflows with human supervision, governance, transparency, and performance measurement built into the process. Flezi Foundry operates through two service modes: Agentic Development Lifecycle (ADLC) supports software development by using specialize

Boomi Named One of The Sunday Times Best Places to Work 202622.5.2026 09:00:00 EEST | Press release

Boomi, the data activation company for AI, has today been named one of The Sunday Times Best Places to Work 2026 in the Medium Organisation category. The prestigious annual list, produced by The Sunday Times in partnership with global workplace analytics company WorkL, recognises the UK's finest employers based entirely on direct employee feedback, making it one of the most credible and transparent employer benchmarks in the country. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521069859/en/ Boomi Named One of The Sunday Times Best Places to Work 2026 Boomi's results speak to a workplace culture that goes well beyond industry norms. The company achieved an average employee happiness score of 86%, rated Excellent, with consistent scores across all six dimensions of WorkL's framework. Most strikingly, Boomi's flight risk, the proportion of employees who may be considering leaving, stood at just 3%, against a technology se

LTM Has Issued an Offer to Acquire Randstad’s Technology and Consulting Services Business in Europe and Australia to Scale Domain-Driven Solutions and AI Services22.5.2026 08:09:00 EEST | Press release

LTM and Randstad announced that LTM has issued an offer to acquire Randstad’s Technology and Consulting Servicesbusiness in France, Germany, Belgium, Luxembourg and Australia, representing USD 500+ million (€469M) in annual revenue, to scale domain-driven solutions and AI services in the region. The proposed acquisition would expand LTM’s presence in key markets, primarily across Aerospace & Defence, Automotive, Utilities and BFS. It would enable local domain expertise and complementary regional capabilities in domain-driven digital engineering, cybersecurity and IoT, supported by onshore and nearshore delivery through centers in Romania and Portugal. This would create a more diversified portfolio for LTM – expanding its scale in Europe and Australia, enhancing its position in regulated and high-growth verticals through marquee customer relationships. The deal would augment LTM’s global AI-centric capabilities with local domain and near-shore expertise crucial for delivering digital an

Polpharma Biologics and Tuteur Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases22.5.2026 08:00:00 EEST | Press release

Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, today announced the signing of a landmark licensing agreement with Argentina-based Tuteur. Under this strategic partnership, Tuteur will obtain exclusive rights to commercialize a biosimilar for autoimmune diseases across Latin America (LATAM), excluding Brazil. Polpharma Biologics will retain full responsibility for the development and manufacturing of the biosimilar. Tuteur will be responsible for commercialization, marketing, and distribution in the licensed territories. This collaboration reflects a shared commitment to expanding patient access to high-quality, affordable biological therapies across the region. “Partnering with Tuteur represents an important step in advancing our mission to broaden access to biosimilars globally,” said Anjan Selz, CEO of Polpharma Biologics. “With their strong regional expertise and commercial capabilities in LATAM, we are well

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye